🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
3.720
-0.050 (-1.33%)
At close: Nov 20, 2026, 4:00 PM EST
3.710
-0.010 (-0.27%)
After-hours: Nov 20, 2026, 7:56 PM EST

Taysha Gene Therapies Revenue

Taysha Gene Therapies had revenue of $5.49M in the twelve months ending September 30, 2026, down -13.07% year-over-year. In the year 2025, Taysha Gene Therapies had annual revenue of $9.77M with 17.28% growth. That makes Taysha Gene Therapies the 39,713th largest company in the world by revenue and 5,260th in the United States.

Revenue (ttm)
$5.49M
Revenue Growth
-13.07%
P/S Ratio
221.13
Revenue / Employee
$55,404
Employees
99
Market Cap
1.21B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.77M1.44M17.28%
Dec 31, 20248.33M-7.12M-46.07%
Dec 31, 202315.45M12.95M517.55%
Dec 31, 20222.50M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Innoviva438.32M
MannKind413.37M
Novavax411.65M
Ocular Therapeutix50.38M
Silence Therapeutics456.00K
Revenue Rankings